- The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer2012 | Third Faculty of Medicine
- A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)2012 | Third Faculty of Medicine
- Endocrine complications of modern cancer therapy2016 | Faculty of Medicine in Hradec Králové
- Biologické účinky bexarotenu u kožního lymfomu z T-buněk. Překlad (Budgin, JA. - Richardson, S. K. - Newton SB. : Biological Effects of Bexarotene in Cutaneous T-Cell Lymphoma)2005 | First Faculty of Medicine
- Biologické účinky bexarotenu u kožního lymfomu z T-buněk. (Budgin, J. B. - Richardson, S. K. - Newton, S. B. - Wisocka, M. - et al. : Biological Effects of Bexarotene in Cutaneous T-Cell Lymhoma)2004 | First Faculty of Medicine
- Primary cutaneous lymphomas in dermatological practice +12018 | Third Faculty of Medicine
- Randomized phase III trial comparing bexarotene (L106949)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I2008 | Third Faculty of Medicine
- Retinoids in Dermatology2017 | First Faculty of Medicine
- Brentuximab vedotin in the treatment of relapsed CD30 positive cutaneous lymphoma - results of an international, open label, randomised, phase 3, multicentre trial - ALCANZA2018 | Faculty of Medicine in Hradec Králové
- Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience2022 | First Faculty of Medicine